肺大细胞神经内分泌癌患者的治疗选择。
Treatment options for patients with large cell neuroendocrine carcinoma of the lung.
作者信息
Iyoda Akira, Makino Takashi, Koezuka Satoshi, Otsuka Hajime, Hata Yoshinobu
机构信息
Division of Chest Surgery, Department of Surgery, School of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan,
出版信息
Gen Thorac Cardiovasc Surg. 2014 Jun;62(6):351-6. doi: 10.1007/s11748-014-0379-9. Epub 2014 Apr 10.
Abstract
Large cell neuroendocrine carcinoma (LCNEC) of the lung is categorized as a variant of large cell carcinomas, and LCNEC tumors display biological behaviors resembling those of small cell lung carcinomas and features of high-grade neuroendocrine tumors. Because patients with LCNEC have a poor prognosis, surgery alone is not sufficient. Multimodality therapies, including adjuvant chemotherapy, appear promising for improved prognosis in patients with LCNEC. In this review article, we discuss treatment options for patients with LCNEC of the lung.
摘要
肺大细胞神经内分泌癌（LCNEC）被归类为大细胞癌的一种变体，LCNEC肿瘤表现出类似于小细胞肺癌的生物学行为以及高级别神经内分泌肿瘤的特征。由于LCNEC患者预后较差，单纯手术并不足够。包括辅助化疗在内的多模式治疗对于改善LCNEC患者的预后似乎很有前景。在这篇综述文章中，我们讨论了肺LCNEC患者的治疗选择。
相似文献
1
Treatment options for patients with large cell neuroendocrine carcinoma of the lung.肺大细胞神经内分泌癌患者的治疗选择。
Gen Thorac Cardiovasc Surg. 2014 Jun;62(6):351-6. doi: 10.1007/s11748-014-0379-9. Epub 2014 Apr 10.
2
Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.肺大细胞神经内分泌癌：其在肺癌谱系中的地位。
Ann Thorac Surg. 2007 Aug;84(2):702-7. doi: 10.1016/j.athoracsur.2007.03.093.
3
A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.肺外周、小细胞型高级神经内分泌肿瘤的临床病理研究：小细胞肺癌与大细胞神经内分泌癌的区别。
Eur J Cardiothorac Surg. 2012 Apr;41(4):841-6. doi: 10.1093/ejcts/ezr132. Epub 2011 Dec 21.
4
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.肺大细胞神经内分泌癌的围手术期辅助化疗的临床反应。
Anticancer Drugs. 2010 Jan;21(1):89-93. doi: 10.1097/CAD.0b013e328330fd79.
5
Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.免疫组织化学研究肺大细胞神经内分泌癌：神经内分泌标志物染色模式与化疗反应之间的可能关联。
J Thorac Cardiovasc Surg. 2013 Mar;145(3):839-46. doi: 10.1016/j.jtcvs.2012.03.036. Epub 2012 Apr 11.
6
Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience.肺大细胞神经内分泌癌的外科治疗：10 年经验。
Eur J Cardiothorac Surg. 2013 Jan;43(1):111-4. doi: 10.1093/ejcts/ezs174. Epub 2012 Apr 23.
7
Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.纯型和混合型肺大细胞神经内分泌癌患者临床结局的差异：一项多中心回顾性研究。
Lung Cancer. 2020 Jan;139:118-123. doi: 10.1016/j.lungcan.2019.11.004. Epub 2019 Nov 11.
8
Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection.肺大细胞神经内分泌癌及具有神经内分泌形态的肺大细胞癌：完全切除及系统性淋巴结清扫后的预后
Ann Thorac Surg. 2003 Feb;75(2):348-52. doi: 10.1016/s0003-4975(02)04118-8.
9
Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.肺小细胞癌与大细胞神经内分泌癌的临床与病理差异。
Ann Surg Oncol. 2024 Sep;31(9):5697-5705. doi: 10.1245/s10434-024-15505-4. Epub 2024 May 29.
10
Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.肺混合性大细胞神经内分泌癌经纳武利尤单抗治疗后长期生存。
Thorac Cancer. 2020 Jul;11(7):2036-2039. doi: 10.1111/1759-7714.13471. Epub 2020 May 7.
引用本文的文献
1
Pulmonary Large-Cell Neuroendocrine Carcinoma, a Multifaceted Disease-Case Report and Literature Review.肺大细胞神经内分泌癌：一则多方面病例报告及文献综述
Diagnostics (Basel). 2025 Apr 22;15(9):1056. doi: 10.3390/diagnostics15091056.
2
Large-Cell Neuroendocrine Carcinoma of the Cervix: Case Report and Literature Review.宫颈大细胞神经内分泌癌：病例报告及文献综述
Diagnostics (Basel). 2025 Mar 19;15(6):775. doi: 10.3390/diagnostics15060775.
3
Perioperative serplulimab‑based chemoimmunotherapy in stage IV large cell neuroendocrine carcinoma of the lung: A case report.围手术期基于斯鲁利单抗的化疗免疫疗法治疗IV期肺大细胞神经内分泌癌：一例报告
Oncol Lett. 2024 Sep 12;28(5):547. doi: 10.3892/ol.2024.14680. eCollection 2024 Nov.
4
Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.肺切除高级别神经内分泌癌的预后因素和列线图：20 年单机构真实世界经验。
Orphanet J Rare Dis. 2024 Jun 12;19(1):232. doi: 10.1186/s13023-024-03240-8.
5
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma.基于最小绝对收缩和选择算子Cox回归的肺大细胞神经内分泌癌患者预后列线图。
Transl Cancer Res. 2024 Feb 29;13(2):916-934. doi: 10.21037/tcr-23-1061. Epub 2024 Jan 24.
6
Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study.肺大细胞神经内分泌癌：一项基于人群的回顾性队列研究。
J Clin Med. 2023 Jun 19;12(12):4126. doi: 10.3390/jcm12124126.
7
Pulmonary Large Cell Neuroendocrine Carcinoma.肺大细胞神经内分泌癌。
Pathol Oncol Res. 2022 Oct 11;28:1610730. doi: 10.3389/pore.2022.1610730. eCollection 2022.
8
Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues.肺神经内分泌肿瘤的外科治疗原则：未解决的问题和有争议的技术问题。
Curr Treat Options Oncol. 2022 Dec;23(12):1645-1663. doi: 10.1007/s11864-022-01026-3. Epub 2022 Oct 21.
9
F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer.用于预测非小细胞肺癌隐匿性淋巴结转移的F-FDG PET/CT影像组学列线图
Front Oncol. 2022 Sep 28;12:974934. doi: 10.3389/fonc.2022.974934. eCollection 2022.
10
Construction and validation of nomograms based on the log odds of positive lymph nodes to predict the prognosis of lung neuroendocrine tumors.基于阳性淋巴结对数优势比构建并验证列线图预测肺神经内分泌肿瘤预后。
Front Immunol. 2022 Sep 23;13:987881. doi: 10.3389/fimmu.2022.987881. eCollection 2022.
本文引用的文献
1
Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma.肺大细胞神经内分泌癌患者的临床病理特征及恶性肿瘤新TNM分类的影响
Mol Clin Oncol. 2013 May;1(3):437-443. doi: 10.3892/mco.2013.80. Epub 2013 Feb 28.
2
Multimodality therapy for large cell neuroendocrine carcinoma of the thymus.胸腺癌的大细胞神经内分泌癌的多模态治疗。
Ann Thorac Surg. 2013 Oct;96(4):e85-e87. doi: 10.1016/j.athoracsur.2013.04.107.
3
Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literature.伴有表皮生长因子受体（EGFR）基因突变及腺癌标志物共表达的肺大细胞神经内分泌癌：一例报告并文献复习
Multidiscip Respir Med. 2013 Jul 18;8(1):47. doi: 10.1186/2049-6958-8-47.
4
Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study.含伊立替康和顺铂的联合化疗治疗肺大细胞神经内分泌癌：一项多中心 II 期研究。
J Thorac Oncol. 2013 Jul;8(7):980-4. doi: 10.1097/JTO.0b013e31828f6989.
5
Combined large cell neuroendocrine carcinoma and adenocarcinoma with epidermal growth factor receptor mutation in a female patient who never smoked.一名从不吸烟的女性患者合并大细胞神经内分泌癌和腺癌，且存在表皮生长因子受体突变。
Ann Thorac Cardiovasc Surg. 2014;20 Suppl:582-4. doi: 10.5761/atcs.cr.12.02217. Epub 2013 Mar 22.
6
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.多中心二期研究顺铂-依托泊苷化疗治疗晚期大细胞神经内分泌肺癌：GFPC 0302 研究。
Ann Oncol. 2013 Jun;24(6):1548-52. doi: 10.1093/annonc/mdt009. Epub 2013 Feb 13.
7
TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.TrkB/BDNF 信号通路是治疗肺大细胞神经内分泌癌的潜在靶点。
Lung Cancer. 2013 Mar;79(3):205-14. doi: 10.1016/j.lungcan.2012.12.004. Epub 2013 Jan 9.
8
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.大标本诊断的 LCNEC 与小活检标本诊断的可能 LCNEC 之间化疗疗效的比较。
Int J Clin Oncol. 2014 Feb;19(1):63-7. doi: 10.1007/s10147-012-0509-2. Epub 2012 Dec 19.
9
Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.玻璃体内注射贝伐单抗治疗肺大细胞神经内分泌癌转移至虹膜的肿瘤。
Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2243-5. doi: 10.1007/s00417-012-2218-y. Epub 2012 Dec 19.
10
Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma.肺大细胞神经内分泌癌的表达谱分析及潜在治疗分子靶点的鉴定
Exp Ther Med. 2011 Nov;2(6):1041-1045. doi: 10.3892/etm.2011.343. Epub 2011 Aug 24.
Zotero 插件